ondansetron has been researched along with sufentanil in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chalhoub, V; Haddad, F; Hayek, G; Madi-Jebara, S; Yazigi, A | 1 |
| Charuluxananan, S; Kyokong, O; Narasethakamol, A; Promlok, P; Somboonviboon, W | 1 |
| Guglielminotti, J; Li, G; Moitra, V; Prin, M | 1 |
| Al-Huniti, N; Bui, KH; Cheung, SYA; Johnson, TN; Li, J; Xu, H; Zhou, D; Zhou, W | 1 |
| Chen, L; Chen, Q; Han, T; Huang, J; Li, A; Li, Z; Peng, Z; Xu, W; Zhang, J | 1 |
2 review(s) available for ondansetron and sufentanil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Prophylactic Ondansetron for the Prevention of Intrathecal Fentanyl- or Sufentanil-Mediated Pruritus: A Meta-Analysis of Randomized Trials.
Topics: Analgesics, Opioid; Antipruritics; Fentanyl; Humans; Injections, Spinal; Ondansetron; Pruritus; Randomized Controlled Trials as Topic; Sufentanil | 2016 |
2 trial(s) available for ondansetron and sufentanil
| Article | Year |
|---|---|
Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritus after cesarean delivery with intrathecal sufentanil-morphine.
Topics: Adult; Anesthesia, Obstetrical; Antiemetics; Bupivacaine; Cesarean Section; Double-Blind Method; Female; Humans; Injections, Spinal; Morphine; Ondansetron; Postoperative Nausea and Vomiting; Pregnancy; Pruritus; Sufentanil | 2002 |
Low-dose esketamine with sufentanil for postcesarean analgesia in women with gestational diabetes mellitus: a prospective, randomized, double-blind study.
Topics: Analgesia; Diabetes, Gestational; Double-Blind Method; Female; Humans; Infant, Newborn; Ondansetron; Pain; Pregnancy; Prospective Studies; Sufentanil | 2023 |
5 other study(ies) available for ondansetron and sufentanil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Ondansetron for prevention of intrathecal opioids-induced pruritus, nausea and vomiting after cesarean delivery.
Topics: Adult; Analgesics, Opioid; Antiemetics; Cesarean Section; Female; Humans; Morphine; Ondansetron; Postoperative Nausea and Vomiting; Pregnancy; Pruritus; Sufentanil | 2004 |
Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children.
Topics: Acetates; Analgesics, Opioid; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Bronchodilator Agents; Child; Child, Preschool; Cyclopropanes; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diclofenac; Esomeprazole; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Infant, Newborn; Itraconazole; Lansoprazole; Loratadine; Models, Biological; Ondansetron; Pharmaceutical Preparations; Pharmacokinetics; Proton Pump Inhibitors; Quinolines; Serotonin Antagonists; Sufentanil; Sulfides; Theophylline; Tramadol | 2018 |